Research Article

Predicting Hypertensive Disease in the First Trimester of Pregnancy: Risk Models and Analysis of Serum D-dimer Levels Combined with Plasma Pregnancy-Associated Protein A, Free β-Subunit of Human Chorionic Gonadotropin, and Fetal Nuchal Translucency

Table 2

DD, PAPP-A, free β-hCG, and NT concentration and MoM level in the different groups.

GroupsDD (ng/mL)DD MoMPAPP-A (mU/L)PAPP-A MoMFree β-hCG (ng/mL)Free β-hCG MoMNT (cm)NT MoM

Control150226.60 (89.41-367.32)0.84 (0.33-1.36)4495 (1650-13545)0.96 (0.36-2.75)52.65 (16.87-156.23)1.06 (0.40-2.88)1.40 (0.73-2.34)0.95 (0.52-1.53)
GH126269.52 (198.42-335.38)1.00 (0.73-1.26)3420 (837-10430)0.96 (0.40-2.79)42.4 (12.70-121.65)0.97 (0.29-2.54)1.40 (0.70-2.30)0.96 (0.53-1.59)
PE53304.67 (193.88-361.89)1.13 (0.72-1.34)3720 (842-12120)0.93 (0.30-2.20)43.80 (10.61-315.00)0.87 (0.29-6.93)1.30 (0.56-2.71)0.91 (0.40-1.69)
SPE41329.23 (256.03-397.95)1.23 (0.95-1.64)3320 (450-11495)0.81 (0.14-2.74)37.80 (15.10-168.05)0.81 (0.35-2.63)1.20 (0.70-1.95)0.82 (0.52-1.19)
99.80470.32518.2823.91712.9835.5103.7848.475
<0.001<0.001<0.0010.2710.050.1380.2860.037

GH: gestational hypertension; PE: preeclampsia; SPE: severe preeclampsia; DD: D-dimer; PAPP-A: pregnancy-associated plasma protein A; free β-hCG: free beta human chorionic gonadotropin; NT: nuchal translucency; MoM: multiple of median. ; .